Overall survival time and cumulative incidence of bone marrow failure for exon 1 and intron 4/exon 14 FANCCpatients.

(A) Overall survival time of exon 1 and intron 4/exon 14 patients calculated by the Kaplan-Meier method. (B) Cumulative incidence of bone marrow failure in exon 1 and intron 4/exon 14 patients, calculated by a competing-risk approach, in which death is treated as a competing cause of risk.